Stay updated on Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s footer revision/version identifier was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T16:46:10.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:41:39.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; trial details and page content appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-19T22:23:58.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:10:02.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page's revision tag updates from v3.4.1 to v3.4.2 with no visible changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:49:17.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. This appears to be a minor maintenance/update with no changes to the study content.
    Difference
    0.1%
    Check dated 2026-02-04T23:30:10.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page.